Barinthus Biotherapeutics plc
BRNS
$0.63
-$0.01-1.39%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
3/19/2026
-
Ticker Report
3/16/2026
-
PR Newswire
3/16/2026
-
PR Newswire
3/13/2026
-
SeekingAlpha.com: All News
3/13/2026
-
Seeking Alpha - Healthcare
3/13/2026
-
TipRanks Financial Blog
3/13/2026
-
The Fly
3/13/2026
-
Globe Newswire
3/10/2026
-
Zolmax
2/23/2026
-
TipRanks Financial Blog
12/27/2025
-
Ticker Report
Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) Upgraded to Buy: What Does It Mean for the Stock?
12/15/2025
-
Zacks Investment Research
12/10/2025
-
TipRanks Financial Blog
12/10/2025
-
The Fly
12/10/2025
-
Globe Newswire
11/20/2025
-
Globe Newswire
11/19/2025
-
PR Newswire
11/19/2025
-
PR Newswire
11/19/2025
-
Globe Newswire
11/18/2025
-
Globe Newswire
11/17/2025
-
Ticker Report
11/17/2025
-
GuruFocus
11/17/2025
-
TipRanks Financial Blog
11/17/2025
-
The Fly
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, March 13, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 4 and 8 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
443 917 0966
Address
20400 Century Boulevard
Germantown, MD 20874
Germantown, MD 20874
Country
Year Founded
Business Description
Sector
Barinthus Biotherapeutics plc, together with its subsidiaries, engages in the research, development, and commercialization of immunotherapies and vaccines in the United States and the United...
more